Snapshot
Specialty Drug Distribution is a link of pharmaceutical logistics; it distributes Specialty Drug to consumers relying on certain logistics equipment, technology and logistics management information system. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
The Asia-Pacific Specialty Drug Distribution market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Specialty Drug Distribution by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Amerisource
Mckesson
Cardinal Health
PHOENIX
Medipal Holdings
Alliance Healthcare
Celesio
Sinopharm
Accredo
Shanghai Pharma
Anda
Jointown
Max Pharma
Avella
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Retail
Home Health
Clinics
Pharmacies
Region Coverage (Regional Production, Demand & Forecast by Regions etc.):
China
Japan & Korea
India
Southeast Asia
Oceania